A needle-free universal vaccine may soon be on the horizon. Scientists have successfully run the first trial, which showed the vaccine can safely elicit an immune response to several viruses. But more ...

In a new study published in Nature Immunology, researchers at Boston Children's Hospital demonstrated that pairing the original COVID-19 mRNA vaccine with an immune system enhancer, known as an ...

A vaccine won’t be coming soon to help quell the Ebola outbreak raging through the Democratic Republic of Congo. There are no existing vaccines targeted to the species of Ebola that is already ...

Vaccine hesitancy exists along a spectrum; most parents with hesitancy are motivated to protect their children but are often concerned about safety. Routine childhood vaccines recommended by the ...

In a breakthrough poised to reshape cancer treatment, Houston Methodist has developed the first personalized mRNA cancer vaccine designed to prevent recurrence of osteosarcoma, a rare and aggressive ...

Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn't likely coming any time soon. Moderna ...

University of Bath chemist professor Asel Sartbaeva is among those working on a vaccine An international team of scientists is working to create a vaccine against a virus suspected of killing three ...

The new Visual Studio March Update touts "Build Your Own Custom Agents" so I had to immediately try that out. I pointed the IDE's Copilot Chat at an existing Blazor project and had it generate a ...

Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common ...

SYDNEY (WKRC) — An Australian tech entrepreneur's dedication to helping his dog fight cancer is potentially opening doors for better treatments and outcomes in both canines and humans. Paul Conyngham ...

Paul Conyngham used AI to pinpoint the mutations in his dog Rose's tumor — and used the data to have a treatment made just for her Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has ...

When tech entrepreneur Paul Conyngham found out that his dog Rosie had deadly mast-cell cancer, he was devastated. When chemotherapy and surgery didn’t work to shrink the tumors, the electrical and ...